德英生物科技
Inquiry Cart

Important resolutions of the Board of Directors in 2018

Important Resolutions of the Board of Directors in 2018 (Year 107)

▌Note: The table can be scrolled horizontally
Date Main Agenda Resolution
2018.03.09 Agenda 1: The Company’s 2017 Financial Statements submitted for review. With no objection from all attending directors, the proposal was approved. After accountants 林姿妤 and 林永智 of PwC Taiwan complete the audit and certification of the 2017 financial statements, the case will be submitted to the shareholders’ meeting for acknowledgment.
Agenda 2: The Company’s 2017 Business Report and Statement of Loss Compensation submitted for discussion. The proposal was approved with no objections from all attending directors, and will be submitted to the Audit Committee for review and then to the shareholders’ meeting for acknowledgment.
Agenda 3: Engagement of PwC Taiwan to conduct the 2018 financial statement audit and corporate income tax certification submitted for discussion. The proposal was approved with no objections from all attending directors.
Agenda 4: Completion of the Company’s 2017 Internal Control Self-Assessment and issuance of the Internal Control System Statement submitted for discussion. The proposal was approved with no objections from all attending directors.
Agenda 5: Change of the Company’s signing CPAs for the financial statements in line with PwC Taiwan’s internal organizational adjustments submitted for discussion. The proposal to change the Company’s signing CPAs was approved with no objections from all attending directors.
Agenda 6: By-election of one director and one independent director submitted for discussion. The proposal was approved with no objections from all attending directors, and it was resolved to convene another Board meeting on May 9 to review and confirm the candidates’ qualifications and submit them to the Annual Shareholders’ Meeting for election.
Agenda 7: Arrangements for convening the 2018 Annual Shareholders’ Meeting submitted for discussion. The proposal was approved with no objections from all attending directors.
2018.05.09 Agenda 1: Review of the Company’s by-election of one director and one independent director submitted for resolution. After reviewing that the candidates’ qualifications and documentation were in full compliance, the proposal was approved with no objections from all attending directors and will be submitted to the Annual Shareholders’ Meeting for election.
2018.08.03 Agenda 1: Appointment of the new Chief Accounting Officer concurrently serving as Chief Financial Officer submitted for discussion. The personnel appointment was approved with no objections from all attending directors.
Agenda 2: Proposed change of signing CPAs for the Company’s financial statements submitted for discussion. The proposal to change the signing CPAs was approved with no objections from all attending directors.
2018.11.09 Agenda 1: Amendments to the “Training Operations” section of the Company’s Internal Control System submitted for discussion. The amendments were approved with no objections from all attending directors.
2018.12.21 Agenda 1: Establishment of the Company’s 2019 Budget submitted for discussion. The Company’s 2019 Budget was approved with no objections from all attending directors.
Agenda 2: Establishment of the Company’s 2019 Audit Plan submitted for discussion. The Company’s 2019 Audit Plan was approved with no objections from all attending directors.
Agenda 3: Amendments to certain provisions of the Company’s Articles of Incorporation submitted for discussion. The amendments were approved with no objections from all attending directors and will be submitted to the Annual Shareholders’ Meeting for discussion.
Agenda 4: Amendments to certain provisions of the Company’s Accounting System submitted for discussion. The amendments to the Accounting System were approved with no objections from all attending directors.